[1]郭 良,谭 昱,马春涛,等.四妙散加减治疗湿热蕴结型急性痛风性关节炎疗效及对患者T细胞亚群、血液流变学及炎性标志物的影响[J].陕西中医,2023,(2):199-204.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.014]
　GUO Liang,TAN Yu,MA Chuntao,et al.Effect of Simiao powder on T cell subsets,hemorheology and inflammatory markers in acute gouty arthritis of damp-heat accumulation type[J].,2023,(2):199-204.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.014]
点击复制

四妙散加减治疗湿热蕴结型急性痛风性关节炎疗效及对患者T细胞亚群、血液流变学及炎性标志物的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年2期
页码:
199-204
栏目:
临床研究
出版日期:
2023-02-05

文章信息/Info

Title:
Effect of Simiao powder on T cell subsets,hemorheology and inflammatory markers in acute gouty arthritis of damp-heat accumulation type
作者:
郭 良; 谭 昱; 马春涛; 陈立刚; 白曼莫
(三亚市中医院,海南 三亚 572022)
Author(s):
GUO Liang; TAN Yu; MA Chuntao; CHEN Ligang; BAI Manmo
(Sanya Traditional Chinese Medicine Hospital,Sanya 572022,China)
关键词:
急性痛风性关节炎;  四妙散;  湿热蕴结型;  T细胞亚群;  血液流变学
Keywords:
Acute gouty arthritis;  Simiao powder;  Damp heat accumulation type;  T cell subsets;  Hemorheology
分类号:
R 684.3
DOI:
DOI:10.3969/j.issn.1000-7369.2023.02.014
文献标志码:
A
摘要:
目的:探究四妙散加减治疗对湿热蕴结型急性痛风性关节炎(AGA)患者T细胞亚群、血液流变学及炎性标志物水平的影响。方法:选取湿热蕴结型AGA患者104例,分为塞来昔布组49例(口服塞来昔布胶囊治疗)和四妙散组(在塞来昔布组基础上给予四妙散加减治疗)55例,治疗3个月后,比较两组患者疗效、治疗前后中医症状积分、T细胞亚群、血尿酸(SUA)、全血黏度、血浆黏度、红细胞沉降率(ESR)、红细胞电泳(EEP)、纤维蛋白原(Fib)、高敏C-反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、白介素-1β(IL-1β)、白介素-6(IL-6)、白介素-8(IL-8)、白介素-17(IL-17)、8-羟基脱氧鸟苷(8-OHdG)、硝基络氨酸修饰蛋白(3-NT)、丙二醛(MDA)水平、疼痛评分(VAS)和不良反应发生率。结果:治疗后,四妙散组治疗总有效率、CD3+、CD8+水平明显高于塞来昔布组,临床症状积分、CD4+、CD4/CD8、SUA、血流动力学指标(全血黏度、血浆黏度、ESR、EEP、Fib)、炎性标志物(hs-CRP、TNF-α、IL-1β、IL-6、IL-8、IL-17)、MDA、3-NT、8-OHdG水平、VAS评分、总不良反应发生率低于塞来昔布组(均P<0.05)。结论:四妙散加减能改善湿热蕴结型急性痛风性关节炎患者的临床症状、T细胞亚群和血液流变学指标,降低血尿酸,减轻疼痛,抑制炎症反应,降低氧化应激表达,减少不良反应发生。
Abstract:
Objective:To explore the effect of modified Simiao powder on T cell subsets,hemorheology and inflammatory markers in patients with acute gouty arthritis(AGA)of damp-heat accumulation type.Methods:A total of 104 patients with damp-heat accumulation type AGA were retrospectively selected.According to different treatment methods,they were divided into celecoxib group(49 cases,treated with oral celecoxib capsules)and Simiao powder group(55 cases,treated with Simiao powder on the basis of celecoxib group ).The curative effect,TCM symptom score,T cell subsets,blood uric acid(SUA),whole blood viscosity(ηb),plasma viscosity(ηp),erythrocyte sedimentation rate(ESR),erythrocyte electrophoresis(EEP),fibrinogen(Fib),high-sensitivity C-reactive protein(hs-CRP),tumor necrosis factor-α(TNF-α),interleukin-1β(IL-1β),interleukin-6(IL-6),interleukin-8(IL-8),interleukin-17(IL-17),8-hydroxydeoxyguanosine(8-OHdG),nitrocytidine modified protein(3-NT),serum malondialdehyde(MDA)level,pain score(VAS)and incidence of adverse reactions were observed and compared between the two groups.Results:After treatment,the total effective rate,CD3+ and CD8+ levels in the Simiao powder group were significantly higher than those in the celecoxib group,and the clinical symptom scores,CD4+,CD4/CD8,SUA,hemorheology(ηb,ηp,ESR,EEP,Fib),inflammatory markers(hs-CRP,TNF-α,IL-1β,IL-6,IL-8,IL-17),MDA,3-NT,8-OHdG levels,VAS score and total adverse reaction rate were significantly lower than those in the celecoxib group(all P<0.05).Conclusion:Modified Simiao powder can improve the clinical symptoms,T cell subsets and hemorheological indexes of patients with acute gouty arthritis of damp-heat accumulation type,reduce blood uric acid,relieve pain,inhibit inflammatory reaction,reduce oxidative stress expression,and reduce adverse reactions.

参考文献/References:

[1] 李芨慧,李玉宏,葛丽丽.急性痛风性关节炎患者肌骨超声半定量评分与红细胞沉降率、白细胞介素-6水平及疾病活动度相关性分析[J].陕西医学杂志,2022,51(3):318-321.
[2] 罗明辉,刘金文.基于数据挖掘探讨中医药治疗痛风性关节炎用药规律[J].陕西中医,2020,41(9):1320-1323.
[3] 潘显阳,陶金辉,李向培.痛风性关节炎发病的炎性机制研究进展[J].安徽医科大学学报,2021,56(7):1167-1171.
[4] 赵 敏,陈 婷,黄振光,等.1990—2019年中国痛风疾病负担研究[J].现代预防医学,2021,48(21):3974-3978.
[5] 张静雯,王 利,赵 敏,等.核苷酸结合寡聚化结构域样受体蛋白3介导细胞焦亡在痛风性关节炎中的作用机制研究[J].陕西医学杂志,2022,51(5):561-565.
[6] 唐桂军,郭泉滢,李培旭.李培旭清热益气通络法治疗痛风性关节炎经验总结[J].陕西中医,2019,40(12):1759-1761.
[7] Strobl S,Halpern EJ,Ellah MA,et al.Acute gouty knee arthritis:Ultrasound findings compared with dual-energy CT findings[J].Am J Roentgenol,2018,210(6):1323-1329.
[8] 刘 维,曾 苹,吴 越,等.痛风性关节炎中西医诊疗概况[J].风湿病与关节炎,2021,10(5):62-65,72.
[9] 郑艳艳,王华杰,尹治军.不同证型痛风性关节炎患者中医症候的分析[J].深圳中西医结合杂志,2020,30(23):62-63.
[10] 舒建龙,李凤珍,覃裕旺.痛风病理及临床中西医治疗的研究进展[J].中国实验方剂学杂志,2020,26(2):218-227.
[11] 中华医学会风湿病学分会.原发性痛风诊断和治疗指南[J].中华风湿病学杂志,2011,15(6):410-413.
[12] 国家中医药管理局.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2012:50.
[13] 国家食品药品监督管理总局.中药新药临床研究指导原则[M].北京:中国中医药科技出版社,1995:179-183.
[14] 中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:75.
[15] Chiarotto A,Maxwell LJ,Ostelo RW,et al.Measurement properties of visual analogue scale,numeric rating scale,and pain severity subscale of the brief pain inventory in patients with low back pain:A systematic review[J].J Pain,2019,20:245-263.
[16] 欧阳香,丁 婷,杨海艳,等.痛风性关节炎发病机制相关信号通路的研究进展[J].中药药理与临床,2021,37(4):234-240.
[17] 朱克强,王 晨,惠晓艳,等.肿瘤坏死因子-α在痛风性关节炎发病机制中的作用研究进展[J].浙江医学,2020,42(6):638-641.
[18] 姜德友,李文昊,解 颖,等.嘌呤配体P2X门控离子通道型受体7及其下游分子在痛风性关节炎中作用机制的研究进展[J].世界中医药,2020,15(8):1221-1224.
[19] 方茹璐,徐巧璐,葛 晓,等.462例痛风患者合并症或并发症及其相关因素研究[J].新中医,2022,54(12):258-262.
[20] 蓝桂彬,赖春进,宁丽晔.银杏叶提取物注射液治疗老年缺血性脑血管病的疗效与安全性[J].中国医药科学,2018,8(3):86-88.
[21] 杨玉红,李晓涛,李金宝,等.四妙散加减治疗阿司匹林诱发的急性痛风性关节炎湿热蕴结证的临床观察[J].中国临床医生杂志,2022,50(2):241-243.
[22] 陈学琴,刘永梅,马喜喜,等.类风湿关节炎与痛风关节炎患者身心健康、炎症状态及免疫功能的比较[J].现代生物医学进展,2020,20(13):2585-2588,2550.
[23] 张 宏,王旭昀,吕翠岩,等.血尿酸的来源去路及痛风关节炎的中医辨治[J].医学综述,2018,24(8):1617-1620,1626.
[24] 赵学刚,刘晓敏,李 丽.超声引导下注射糖皮质激素治疗急性痛风关节炎临床有效性及对ESR、CRP水平的影响[J].影像研究与医学应用,2020,4(7):182-184.
[25] 金秀娟,陆继娣.泄浊痛风汤结合秋水仙碱片治疗痛风关节炎的临床疗效及对TNF-α、IL-1β水平的影响[J].四川中医,2019,37(4):143-145.
[26] 方 磊,石汉振,李雅茜,等.伤柏膏对急性痛风关节炎患者的影响[J].国际医药卫生导报,2021,27(16):2525-2529.
[27] 胡 青,戴 冰,徐文峰,等.四妙白虎汤加减结合秋水仙碱片治疗湿热蕴结型急性痛风性关节炎疗效及对炎性指标的影响[J].现代中西医结合杂志,2021,30(28):3147-3150.

相似文献/References:

[1]张静雯,吕艳艳,刘 洋,等.痹症1号对急性痛风性关节炎患者血清炎性因子水平变化的研究*[J].陕西中医,2019,(10):1411.
　ZHANG Jingwen,LV Yanyan,LIU Yang,et al.Study on the changes of serum inflammatory factors of patientswith acute gouty arthritis treated with Bizheng No.1[J].,2019,(2):1411.
[2]边卓琼,张 薇,姜 敏△,等.痹症1号联合醋氯芬酸片治疗湿热蕴结型急性痛风性关节炎疗效研究*[J].陕西中医,2019,(10):1415.
[3]魏 薇,李鹏鸟,张向阳,等.关节肿痛散联合针刺治疗对急性痛风性关节炎患者滑膜及关节功能的影响[J].陕西中医,2022,(12):1801.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.038]
　WEI Wei,LI Pengniao,ZHANG Xiangyang,et al.Effects of Guanjie Zhongtong San combined with acupuncture on synovial function and joint function in patients with acute gouty arthritis[J].,2022,(2):1801.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.038]
[4]陈 佳,李 偲,王鸿雁.罗浮山风湿膏药外敷联合秋水仙碱片内服对急性痛风性关节炎患者血尿酸水平及促炎因子的影响[J].陕西中医,2023,(1):80.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.019]
　CHEN Jia,LI Cai,WANG Hongyan.Effect of external application of Luofu Shan rheumatism plaster combined with colchicine tablets on serum uric acid level and proinflammatory factors in patients with acute gouty arthritis[J].,2023,(2):80.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.019]
[5]王赓丰,马俊福,邓雍钲,等.基于NF-κB通路探讨痛风汤对急性痛风性关节炎模型大鼠炎症的影响机制[J].陕西中医,2024,(6):740.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.004]
　WANG Gengfeng,MA Junfu,DENG Yongzheng,et al.Study on the mechanism of Tongfeng decoction on acute gouty arthritis model rats based on NF-κB pathway[J].,2024,(2):740.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.004]

备注/Memo

备注/Memo:
基金项目:海南省卫生健康行业科研项目(21A200429)
更新日期/Last Update: 2023-02-08